This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schrag, D. Articles by Begg, C. B. Search for Related Content PubMed PubMed Citation Articles by Schrag, D. Articles by Begg, C. B.

Who Gets Adjuvant Treatment for Stage II and III Rectal Cancer? Insight From Surveillance, Epidemiology, and End Results–Medicare

From the Departments of Epidemiology and Biostatistics, Medicine, Surgery, and Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY.

Address reprint requests to Deborah Schrag, MD, Health Outcomes Research Group, Department of Epidemiology and Biostatistics Memorial-Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021; email: schragd{at}mskcc.org

PURPOSE: To examine the relationship between patient characteristics and the use of adjuvant pelvic radiation with and without chemotherapy among patients aged 65 years and older with stage II and III rectal cancer.

PATIENTS AND METHODS: A retrospective cohort study using the Surveillance, Epidemiology, and End Results–Medicare linked database identified 1,411 patients aged 65 and older with resected stage II and III rectal cancers diagnosed between 1992 and 1996. From claims submitted to Medicare, we measured the use of pelvic radiation therapy with or without chemotherapy and pre- or postoperatively.

RESULTS: Fifty-seven percent of patients received radiation, 42% received chemotherapy and radiation, and 7% had treatment delivered preoperatively. Age was the strongest determinant of treatment: 73% of patients aged 65 to 69, 66% aged 70 to 75, 52% aged 75 to 79, 39% aged 80 to 84, and 21% aged 85 to 89 received radiation. The age trend remained strong after adjusting for other factors that predict receipt of treatment and after exclusion of patients with any evident comorbidity (P < .001). Patients were more likely to receive radiation treatment if they had an abdominal perineal resection, stage III disease, or a T4 tumor.

CONCLUSION: Because pelvic recurrences are a substantial cause of morbidity, further efforts are needed to ensure that elderly patients have the opportunity to make informed decisions regarding adjuvant treatment.

This article has been cited by other articles:

				N. F. Esnaola, A. K. Stewart, B. W. Feig, J. M. Skibber, and M. A. Rodriguez-Bigas Age-, Race-, and Ethnicity-Related Differences in the Treatment of Nonmetastatic Rectal Cancer: A Patterns of Care Study From the National Cancer Data Base Ann. Surg. Oncol., November 1, 2008; 15(11): 3036 - 3047. [Abstract] [Full Text] [PDF]

				H. Le, A. Ziogas, S. M. Lipkin, and J. A. Zell Effects of Socioeconomic Status and Treatment Disparities in Colorectal Cancer Survival Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1950 - 1962. [Abstract] [Full Text] [PDF]

				T. Kinsey, A. Jemal, J. Liff, E. Ward, and M. Thun Secular Trends in Mortality From Common Cancers in the United States by Educational Attainment, 1993-2001 J Natl Cancer Inst, July 16, 2008; 100(14): 1003 - 1012. [Abstract] [Full Text] [PDF]

				M. B. Landrum, E. R. Meara, A. Chandra, E. Guadagnoli, and N. L. Keating Is Spending More Always Wasteful? The Appropriateness Of Care And Outcomes Among Colorectal Cancer Patients Health Aff., January 1, 2008; 27(1): 159 - 168. [Abstract] [Full Text] [PDF]

				N. K. LoConte Disparities in Cancer Care for Older Adults J. Oncol. Pract, January 1, 2007; 3(1): 51 - 51. [Full Text] [PDF]

				C. P. Gross, G. J. McAvay, H. M. Krumholz, A. D. Paltiel, D. Bhasin, and M. E. Tinetti The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med, November 7, 2006; 145(9): 646 - 653. [Abstract] [Full Text] [PDF]

				P. M. Johnson, G. A. Porter, R. Ricciardi, and N. N. Baxter Increasing Negative Lymph Node Count Is Independently Associated With Improved Long-Term Survival in Stage IIIB and IIIC Colon Cancer J. Clin. Oncol., August 1, 2006; 24(22): 3570 - 3575. [Abstract] [Full Text] [PDF]

				B. N. Polite, J. J. Dignam, and O. I. Olopade Colorectal Cancer Model of Health Disparities: Understanding Mortality Differences in Minority Populations J. Clin. Oncol., May 10, 2006; 24(14): 2179 - 2187. [Abstract] [Full Text] [PDF]

				B. K. Edwards, M. L. Brown, P. A. Wingo, H. L. Howe, E. Ward, L. A. G. Ries, D. Schrag, P. M. Jamison, A. Jemal, X. C. Wu, et al. Annual Report to the Nation on the Status of Cancer, 1975-2002, Featuring Population-Based Trends in Cancer Treatment J Natl Cancer Inst, October 5, 2005; 97(19): 1407 - 1427. [Abstract] [Full Text] [PDF]

				J. N. Cormier, Y. Xing, M. Ding, J. E. Lee, P. F. Mansfield, J. E. Gershenwald, M. I. Ross, and X. L. Du Population-Based Assessment of Surgical Treatment Trends for Patients With Melanoma in the Era of Sentinel Lymph Node Biopsy J. Clin. Oncol., September 1, 2005; 23(25): 6054 - 6062. [Abstract] [Full Text] [PDF]

				E. B. Lamont, J. E. Herndon II, J. C. Weeks, I. C. Henderson, R. Lilenbaum, R. L. Schilsky, N. A. Christakis, and for the Cancer and Leukemia Group B Criterion Validity of Medicare Chemotherapy Claims in Cancer and Leukemia Group B Breast and Lung Cancer Trial Participants J Natl Cancer Inst, July 20, 2005; 97(14): 1080 - 1083. [Abstract] [Full Text] [PDF]

				J. R. Gonzalez, E. Fernandez, V. Moreno, J. Ribes, M. Peris, M. Navarro, M. Cambray, and J. M. Borras Sex differences in hospital readmission among colorectal cancer patients J Epidemiol Community Health, June 1, 2005; 59(6): 506 - 511. [Abstract] [Full Text] [PDF]

				N. L. Keating, M. B. Landrum, E. Meara, P. A. Ganz, and E. Guadagnoli Do Increases in the Market Share of Managed Care Influence Quality of Cancer Care in the Fee-For-Service Sector? J Natl Cancer Inst, February 16, 2005; 97(4): 257 - 264. [Abstract] [Full Text] [PDF]

				N. N. Baxter, D. J. Virnig, D. A. Rothenberger, A. M. Morris, J. Jessurun, and B. A. Virnig Lymph Node Evaluation in Colorectal Cancer Patients: A Population-Based Study J Natl Cancer Inst, February 2, 2005; 97(3): 219 - 225. [Abstract] [Full Text] [PDF]

				E. C. Schneider, A. M. Epstein, J. L. Malin, K. L. Kahn, and E. J. Emanuel Developing a System to Assess the Quality of Cancer Care: ASCO's National Initiative on Cancer Care Quality J. Clin. Oncol., August 1, 2004; 22(15): 2985 - 2991. [Full Text] [PDF]

				J. Z. Ayanian, E. A. Chrischilles, R. B. Wallace, R. H. Fletcher, M. N. Fouad, C. I. Kiefe, D. P. Harrington, J. C. Weeks, K. L. Kahn, J. L. Malin, et al. Understanding Cancer Treatment and Outcomes: The Cancer Care Outcomes Research and Surveillance Consortium J. Clin. Oncol., August 1, 2004; 22(15): 2992 - 2996. [Full Text] [PDF]

				F. L. Greene, A. K. Stewart, and H. J. Norton New Tumor-Node-Metastasis Staging Strategy for Node-Positive (stage III) Rectal Cancer: An Analysis J. Clin. Oncol., May 15, 2004; 22(10): 1778 - 1784. [Abstract] [Full Text] [PDF]

				A. M. Morris, K. G. Billingsley, N. N. Baxter, and L.-M. Baldwin Racial Disparities in Rectal Cancer Treatment: A Population-Based Analysis Arch Surg, February 1, 2004; 139(2): 151 - 155. [Abstract] [Full Text] [PDF]

				M. K. Krzyzanowska, J. C. Weeks, and C. C. Earle Treatment of Locally Advanced Pancreatic Cancer in the Real World: Population-Based Practices and Effectiveness J. Clin. Oncol., September 15, 2003; 21(18): 3409 - 3414. [Abstract] [Full Text] [PDF]

				J. Z. Ayanian, A. M. Zaslavsky, C. S. Fuchs, E. Guadagnoli, C. M. Creech, R. D. Cress, L. C. O'Connor, D. W. West, M. E. Allen, R. E. Wolf, et al. Use of Adjuvant Chemotherapy and Radiation Therapy for Colorectal Cancer in a Population-Based Cohort J. Clin. Oncol., April 1, 2003; 21(7): 1293 - 1300. [Abstract] [Full Text] [PDF]

				J. L. WERTH Jr., D. BLEVINS, K. L. TOUSSAINT, and M. R. DURHAM The Influence of Cultural Diversity on End-of-life Care and Decisions American Behavioral Scientist, October 1, 2002; 46(2): 204 - 219. [Abstract] [PDF]

				J.E. Tepper, M. O'Connell, D. Niedzwiecki, D.R. Hollis, A.B. Benson III, B. Cummings, L.L. Gunderson, J.S. Macdonald, J.A. Martenson, and R.J. Mayer Adjuvant Therapy in Rectal Cancer: Analysis of Stage, Sex, and Local Control--Final Report of Intergroup 0114 J. Clin. Oncol., April 1, 2002; 20(7): 1744 - 1750. [Abstract] [Full Text] [PDF]

				J. E. Tepper Adjuvant Radiation Therapy of Rectal Cancer J. Clin. Oncol., September 1, 2001; 19(17): 3709 - 3711. [Full Text] [PDF]